| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/09/2002 | US20020055636 Pyrroloquinolones as antiviral agents |
| 05/09/2002 | US20020055635 Cycloalkano-indole and -azaindole derivatives |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055517 Methods for delaying recurrence of herpes virus symptoms |
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/09/2002 | US20020055513 7-oxo-pyridopyrimidines (II) |
| 05/09/2002 | US20020055502 New compounds, their preparation and use |
| 05/09/2002 | US20020055501 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome. |
| 05/09/2002 | US20020055500 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/09/2002 | US20020054904 Stable pergolide mesylate and process for making same |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202993A2 Phenanthroline-7-one derivatives and their therapeutic uses |
| 05/08/2002 | EP1202992A2 Ascididemin derivatives and their therapeutic applications |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 05/08/2002 | EP1202728A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response |
| 05/08/2002 | EP0723545B1 Quinolizinone type compounds |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/08/2002 | CN1348453A Derivatives of pyrimido [6.1-a] isoquinolin-4-one |
| 05/08/2002 | CN1348452A Derivatives of pyrimido [6,1-a] isoquinolin -4-one |
| 05/08/2002 | CN1348451A Azaindole derivatives for the treatment of depression |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/08/2002 | CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 05/08/2002 | CN1347694A Medicine prepn containing matrine or epimatrine and its application in analgesic medicines |
| 05/07/2002 | US6384235 Preparation of substituted indoles |
| 05/07/2002 | US6384226 Process for the preparation of 2-phenyl-imidazo [1, 2-a] pyridine-3-acetamides |
| 05/07/2002 | US6384222 N-benzenesulfonyl-L-proline compounds, preparation method and method for using the compounds in therapy |
| 05/07/2002 | US6384050 Tricyclic amine derivatives |
| 05/07/2002 | US6384048 Imidazonaphthyridines |
| 05/07/2002 | US6384047 Breathing disorders and hypotensive agents |
| 05/07/2002 | US6384042 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes |
| 05/07/2002 | US6384039 QT dispersion and heart rate variability improvement with CRF antagonists to prevent sudden death |
| 05/07/2002 | CA2098612C Arthropodicidal carboxanilides |
| 05/07/2002 | CA2052263C Herbicides |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034749A1 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 05/02/2002 | WO2002034748A1 Imidazopyridine derivatives |
| 05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034736A1 Process for preparation of bicyclic and polycyclic molecules |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | US20020052507 Process for making 3-amino-2-chloro-4-methylpyridine |
| 05/02/2002 | US20020052502 Cis-substituted aminocyclopropane derivative |
| 05/02/2002 | US20020052500 Reacting perylene-3,4,9,10-tetracarboximide or derivatives with formaldehyde to form bis(hydroxymethyl)perylene-3,4,9,10-tetracarboximide, which further reacts with a precursor of organic redicals |
| 05/02/2002 | US20020052393 Benzanilides as potassium channel openers |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | US20020052359 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/02/2002 | US20020052355 Inhibition of serotonin reuptake; especially 2-(azabicycloalkyl)alkylenyl)isoquinolin-3-one compounds |
| 05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1200434A1 NEW CYTOTOXIC PYRIDO 2,3,4-kl]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| 05/02/2002 | EP1200433A1 C-6 RING-SUBSTITUTED PYRIDO 1,2- i a /i ]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200092A2 Beta-carboline drug products |
| 05/02/2002 | EP1200084A1 Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications |
| 05/02/2002 | EP1200068A2 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 05/02/2002 | EP0846118B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 05/02/2002 | EP0812838B1 Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor |
| 05/02/2002 | DE10053275A1 New 7-aza-indole-3-carboxamides or glyoxylamides, useful e.g. for treating rheumatoid arthritis, osteoporosis, sepsis, asthma or multiple sclerosis are phosphodiesterase-4 and tumor necrosis factor-alpha inhibitors |
| 05/02/2002 | CA2427021A1 Process for preparation of bicyclic and polycyclic molecules |
| 05/02/2002 | CA2426616A1 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 05/01/2002 | CN1347416A Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 05/01/2002 | CN1347415A Tricyclic pyridine N-oxides vasopressin agonists |
| 05/01/2002 | CN1083841C Pyrazolopyridylpyridazinone derivs. and process for preparation thereof |
| 04/30/2002 | USRE37686 Biosynthesis of polypeptides |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380210 Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| 04/30/2002 | US6380209 Highly selective agonists, antagonists or inverse agonists for gaba brain receptors or prodrugs, useful in the diagnosis and treatment of anxiety, down syndrome, sleep, cognitive and seizure disorders |
| 04/30/2002 | US6380208 Administering nicergoline, optionally in combination with a pharmaceutically acceptable carrier for therapy of pyramidal spasticity of neurological diseases involving an attack of the pyramidal pathway |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6380134 N-pyridyl herbicide compounds |
| 04/30/2002 | US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 04/30/2002 | US6379704 Method for preparing microparticles having a selected polymer molecular weight |
| 04/30/2002 | US6379649 Useful for diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors; nerve system disporders |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2001087305A3 Method for treating functional dyspepsia using alosetron |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 04/25/2002 | US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells |
| 04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
| 04/25/2002 | US20020049316 Protease inhibitors |
| 04/25/2002 | US20020049224 Alpha v integrin receptor antagonists |